Ayradia is a drug owned by VIRBAC AH, INC. It is protected by 1 US drug patent filed in 2033. All patents are active. Details of Ayradia’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
Exclusivity Information
Ayradia holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2028. Details of Ayradia's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Oct 11, 2028 |
About Ayradia
Ayradia is a drug
owned by VIRBAC AH, INC.
Ayradia uses
Metronidazole as the active
ingredient.
Active Ingredient:
Ayradia uses
Metronidazole as the active ingredient.
Check out other Drugs and Companies using
Metronidazole ingredient.